Periodic monitoring Active

Key facts

  • In October 2025, 83 measles cases were reported by nine countries in the EU/EEA. Nineteen countries reported zero cases.
  • During the last 12-month period, eight deaths attributable to measles were reported to ECDC by Romania (five), France (two) and the Netherlands (one) 
  • Overall, case numbers decreased compared with the previous months; this is consistent with the seasonality of measles.
  • Supplementary epidemic intelligence surveillance was performed from 9 to 10 December 2025. Sporadic cases were reported in several EU/EEA countries, one outbreak has been detected in Poland. Updates are provided for countries outside EU/EEA.

Overview

Since March 2025, an overall decrease in reported cases has been observed. As expected, the number of cases further declined over the summer months, in line with the known seasonality of measles.

In October 2025, 28 countries reported measles data, with 83 cases reported by nine countries. There were 19 countries that reported zero cases.

Overall, case numbers decreased compared with the previous month, however this may be subject to change in the event of a future retrospective update. The highest case counts were reported by Spain (29), France (14), Germany (13), and Italy (13).

Between 1 November 2024 to 31 October 2025, 30 EU/EEA Member States reported a total of 9 603 measles cases, 6 868 (71.5%) of which were laboratory confirmed.

Of the 9 603 cases with known age, 3 872 (40.3%) were in children under five years; 3 177 (33.1%) cases were aged 15 years or above. The highest notification rates were observed among infants under one year of age (316.8 cases per million) and children aged 1-4 years (163.5 cases per million).

Of 8 993 cases (93.6% of all cases) with a known age and vaccination status, 7 417 (82.5%) were unvaccinated, 826 (9.2%) were vaccinated with one dose of a measles-containing vaccine, 621 (6.9%) were vaccinated with two or more doses, and 113 (1.3%) were vaccinated with an unknown number of doses.

During the 12-month period, eight deaths (case fatality rate (CFR): 0.083%) attributable to measles were reported to ECDC by Romania (five), France (two) and Netherlands (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.

Complementary epidemic intelligence surveillance has been conducted, with data collection between 9 and 10 December 2025. One outbreak has been detected in the EU/EEA, in Poland; sporadic cases have been reported by several EU/EEA countries. Outside the EU/EEA, updates have been provided for England, Canada, Izrael, Ukraine, Mexico, New Zealand, Switzerland, Ukraine, USA as well for WHO AFRO and WHO PAHO regions.

Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to EpiPulse Cases. Data presented in the two monthly reports may differ.

Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:

Denmark reported nine measles cases in 2025 as of 90 December 2025, an increase of one case, reported in November, the previous case was reported in October 2025.

Germany reported 278 confirmed and probable measles cases in 2025 and as of 9 December, an increase by 11 cases since 13 November 2025. No outbreaks have been detected by ECDC EI group.

Ireland reported three cases in week 48, all three in Dublin and North East region. No other cases have been reported in Ireland in last 12 weeks.

The Netherlands reported 538 cases of measles in 2025 and as of 3 December 2025, an increase of 12 cases since 5 November 2025. The recent cases are distributed in small clusters across the country. There is no indication of a national outbreak. In 2025, 62 cases contracted measles abroad, with most of these infections being related to travel to Morocco (39). Other cases had travel histories to Greece, Romania, Vietnam, Türkiye, Belgium, Uganda, Iran, Bosnia and Herzegovina, China, Malaysia, France, Somalia, and Italy.

Poland reported 101 cases of measles, an increase of 28 cases between 31 October and 30 November 2025. On 3 December 2025, media, quoting health authorities, reported about an outbreak of measles with 26 cases in Podkarpacie. Local health authorities are perfoming active contact tracing and follo-up, as well suggesting free vaccination, and limit hospital visitations.

Romania reported 8 454 measles cases and eight deaths in 2025 and as of 30 November 2025, an increase by 21 cases since 31 October 2025. No new deaths were reported in the reporting period. A decreasing trend is observed in 2025, with fewer cases reported per month compared to the same period in 2024.

Spain reported 390 cases as of 30 November 2025, an increase of 11 cases since 9 November 2025. Of the reported cases, 108 were imported and 95 were related to imported cases. No new cases have been reported in the previously reported outbreak on the Canary Islands.

Sweden reported 10 measles cases in 2025 and as of 9 December 2025, an increase of two cases since October 2025.

Epidemiological summary for EU/EEA outermost territories with relevant epidemic intelligence updates:

No new outbreaks or new cases in the recently reported outbreaks have been detected in this reporting period.

Epidemiological summary for select countries outside of the EU/EEA with relevant epidemic intelligence updates:

England reported 847 laboratory confirmed cases from January to 20 November 2025,36 more cases since 23 October 2025. The majority of cases involve children under 10 years of age (69%). Most of the cases have been reported in Hackney and City of London, Birmingham, and Bristol.

Israel reported as of 8 December 2025, an ongoing outbreak of measles with 730 patients being hospitalised, including 12 deaths, mainly in children. On 10 December 2025, 12th death was reported by media, quoting MoH. Currently affected communities are: Jerusalem, Beit Shemesh, Bnei Brak, Harish, Modiin Illit, Nof HaGalil, Kiryat Gat, Ashdod, Safed, Netivot, Haifa, Tiberias, the Mateh Binyamin Regional Council, and Tekoa. Vaccination with MMR is recommended to 12-month-old children with the first dose, and second dose at six years of age. In the outbreak-affected communities, the second vaccine dose is recommended at 18 months, and an extra dose is recommended for 6-11-month old infants in communities with an outbreak or if traveling there.

Switzerland reported 53 measles cases in 2025 as of 1 December 2025.

Ukraine reported 1 453 measles cases from January to October 2025.

New Zealand reported an outbreak of measles with 30 cases across nine regions as of 7 December 2025. According to Health New Zealand, the community transmission may have been occurring since early September this year.

As of 10 November 2025, Canada reported 5 298 cases (4,926 confirmed, 372 probable), including two deaths, both of which occurred in congenital cases of measles who were born pre-term. An outbreak affects 10 jurisdictions. Most of the reported cases are linked to this outbreak (5 233 cases, of which 4 831 confirmed, 402 probable).The reported weekly number of cases has decreased in the past 10 weeks. Thes outbreak has reached it's peak last spring in week 18, 2025.

According to a report by Africa CDC published on 7 December 2025, Cameroon, Mali and Mozambique experience measles outbreaks with moderate risk.

According to the WHO Pan American Health Organization (WHO PAHO) report published on 15 November 2025, 12 912 confirmed cases were reported by 10 countries, of which the majority of cases reported in Canada (5 222), Mexico (5 292), the United States (1 750), and Bolivia (479).

As of 3 December 2025, the US has reported 1 828 confirmed measles cases in 2025, including three deaths in 43 jurisdictions. Majority of the cases (87%) were associated to 46 outbreaks.

As of report on 8 December 2025, Mexico has reported 5 292 confirmed cases, including 24 deaths in weeks 1-46 of 2025. Most of the cases are reported in the region Chihuahua (4 459 confirmed cases, including 21 deaths). One death was reported in each, Jalisco, Durango and Sonora states.

For more information on the provisional number of cases outside the EU/EEA region, please visit the WHO website.

The numbers provided to WHO for EU/EEA countries are from EpiPulse Cases data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.

ECDC assessment

Although most recent cases were acquired through local or community transmission, travel-related cases continue to be reported.

Continued vigilance is essential due to suboptimal vaccination coverage for measles-containing vaccines (MCV) in several EU/EEA countries, the possible introduction from areas with ongoing transmission, and increased travel and population movement during the holiday period.

Actions

ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs that present measles surveillance data from EpiPulse Cases, which are routinely submitted by 30 EU/EEA countries.

ECDC urges EU/EEA public health authorities to focus on the following areas:

  • Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time, as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
  • Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
  • Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
  • Healthcare professionals should be fully vaccinated.
  • Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
  • Address barriers and engage with populations under served by healthcare services. Systemic barriers that impact vaccine uptake in populations which are isolated and under-served by healthcare services need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
  • In light of the upcoming summer holiday season, travellers should check their vaccination status and consult their general practitioner to ensure they are up to date with recommended immunisations prior to departure.


ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.

Latest updates for this event

View all